Blackstone approaches $2.4bn deal for Precision Medical Group

If a deal is reached, existing investors Berkshire Partners and TPG Growth are expected to remain minority investors in the provider of outsourced pharma services.

21 September 2020•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles